Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 08 May 2025

HIF‐1α modulates pancreatic cancer ECM proteins via the TGF‐β1/Smad signaling pathway introduction

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Houle Guo
Zhanxue Zhao
Linxun Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1564655

895 views

Original Research

Published on 01 May 2025

Comparative efficacy of interventional therapy with or without targeted immunotherapy in Child-Pugh B hepatocellular carcinoma patients: a single-center, retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xu-Wei Guo
Man Zhao
Xiao-Ling Duan
Guang-Jie Han
Jin-Feng Wang
Jian-Fei Shi
Xin Han
Fei Yin
Guang Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1541805

992 views

Case Report

Published on 29 Apr 2025

A case report of rare pancreatic lymphoma: wide range of diffuse large B-cell lymphoma located in the body and tail of pancreas

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiang Song
Weiyu Hu
Li Zhang
Tao Mao
Yingli Zhu
Xiaokai Chen
Linlin Ren

Frontiers in Oncology

doi 10.3389/fonc.2025.1563729

1,174 views

Original Research

Published on 29 Apr 2025

HALP score as a prognostic marker for overall survival in advanced pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Nazan Demir
İvo Gökmen
Yasemin Sağdıç Karateke
Ayşegül İlhan
Fatih Yıldız
Duygu Bayır Garbioğlu
Bülent Yıldız

Frontiers in Oncology

doi 10.3389/fonc.2025.1542463

774 views
1 citation

Original Research

Published on 28 Apr 2025

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Li
Jian-Hong Zhong
Xiao-Dong Zhu
Chuang-Ye Han
Jia-Bei Wang
Hong-Zhi Liu
Kuan Hu
Yang-Xun Pan
Hui-Chuan Sun
Tao Peng

Frontiers in Oncology

doi 10.3389/fonc.2025.1515640

1,573 views

Original Research

Published on 24 Apr 2025

Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Di Zeng
Saud Ahmad Saad
Zhen You
Nansheng Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1555369

1,346 views

Original Research

Published on 24 Apr 2025

Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kai Xiong
Kuiyuan Huang
Yulong Liu
Huajin Pang
Peng Chen
Yalu Zheng
Tengzheng Li
Zhangyun Li
Moran Zhang
Dandan Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570029

1,497 views

Original Research

Published on 24 Apr 2025

Identifying novel biomarkers for biliary tract cancer based on volatile organic compounds analysis and machine learning

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jingrong Qian
Qi Liu
Jue Wang
Xuewei Zhuang
Jun Fang

Frontiers in Oncology

doi 10.3389/fonc.2025.1572460

1,098 views

Review

Published on 22 Apr 2025

Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ronit Juthani
Ashish Manne

Frontiers in Oncology

doi 10.3389/fonc.2025.1555963

1,851 views

Original Research

Published on 16 Apr 2025

Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huhu Ren
Jian Chen
Zhiqun Wu
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1566865

953 views

Systematic Review

Published on 16 Apr 2025

Mapping the knowledge domains of literature on hepatocellular carcinoma and liver failure: a bibliometric approach

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jun Pu
Yamin Zhao
Siming Zhang
Tianqi Wu
Ruizi Liu
Tianyi Yuan
Songnian He
Qingyu Hao
Haixia Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1529297

1,805 views

Original Research

Published on 11 Apr 2025

Metabolic syndrome is associated with worse prognosis in elderly patients with hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Junwei Huang
Yiming Tao
Jianguo Yao
Xiaorui Song
Yiming Li
Yiting Yuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1542328

942 views

Mini Review

Published on 08 Apr 2025

Progress on the HIF-1α/VEGF/VEGFR2 signal pathway in hepatic alveolar echinococcosis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Meng-Zhao Xu
Fei Ke
Jin-Ping Chai
Ji-De A
Qing-Long Tan

Frontiers in Oncology

doi 10.3389/fonc.2025.1553125

1,321 views

Review

Published on 08 Apr 2025

Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhixian Ding
Lusheng Wang
Jiting Sun
Lijie Zheng
Yu Tang
Heng Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1526206

2,332 views

Original Research

Published on 07 Apr 2025

Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ashish Manne
Yonghua Bao
Ankur Sheel
Amir Sara
Upender Manne
Kannan Thanikachalam
Ashwini Esnakula
Timothy M. Pawlik
Jordan M. Cloyd
Susan Tsai

Frontiers in Oncology

doi 10.3389/fonc.2025.1544928

1,267 views

Case Report

Published on 04 Apr 2025

Systemic therapy with pemigatinib and sintilimab followed by resection for recurrent FGFR-2-positive intrahepatic cholangiocarcinoma: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuchen Yang
Jingfeng Li
Di Ma
Fengjie Hao
Weixia Li
Jing Xie
Lihan Qian
Junqing Wang
Yongjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1527372

959 views